KPV research: what the published studies show

Identity and the Parent Molecule

KPV is Lys-Pro-Val. It is the C-terminal tripeptide of alpha-melanocyte-stimulating hormone, residues 11 to 13 of that thirteen-residue peptide, and alpha-MSH is a different molecule with a literature of its own. No alpha-MSH-only result appears below.

Intestinal Inflammation

A 2008 study tested the tripeptide in human intestinal epithelial and T-cell lines stimulated with pro-inflammatory cytokines.^[1] Nanomolar concentrations inhibited activation of NF-kappaB and MAP kinase signaling and reduced pro-inflammatory cytokine secretion.^[1] The study reports that KPV enters cells through PepT1, a di- and tripeptide transporter expressed in intestinal epithelial and immune cells.^[1] Oral administration in drinking water reduced the incidence of colitis in two mouse models, DSS and TNBS, with lower pro-inflammatory cytokine expression.^[1]

A second 2008 study, from a different group, used DSS colitis and CD45RB-high T-cell transfer colitis in mice, where animals given the tripeptide recovered earlier and regained significantly more weight.^[2] Inflammatory infiltrates fell significantly on histology.^[2] Myeloperoxidase activity in colonic tissue also fell, and both models showed the same direction of effect.^[2]

A 2017 study loaded the tripeptide into hyaluronic-acid-functionalised nanoparticles of about 272 nanometres.^[3] The particles were given by mouth inside a chitosan-alginate hydrogel, and they prevented mucosal damage and lowered TNF more than the same particles without the hyaluronic acid coat.^[3] What was tested there was a formulation, and its performance is not a measurement of the free tripeptide.^[3]

The Receptor Question, Where the Sources Disagree

A 2004 study measuring signaling in human keratinocytes detected no rise in cyclic AMP in HaCaT or normal human keratinocytes in response to alpha-MSH, KPV or ACTH peptides.^[4] Rapid intracellular calcium responses were seen in HaCaT keratinocytes to alpha-MSH, KPV and KP-D-V across a wide concentration range.^[4] Those responses appeared only in the presence of an adenosine agonist that blocks the cyclic AMP pathway.^[4] In Chinese hamster ovary cells stably transfected with the melanocortin-1 receptor, alpha-MSH and the KPV peptides elevated intracellular calcium.^[4]

The 2008 mouse study reached a different position.^[2] In melanocortin-1-receptor-deficient mice the tripeptide rescued every animal in its group from death during DSS colitis, and its authors conclude the effects seem at least partially independent of that receptor.^[2]

A third source frames the tripeptide as the message sequence itself, stating that the effective message sequence of alpha-MSH resides in the C-terminal tripeptide.^[5]

These three positions are reported as they stand. One reports calcium signaling through a transfected melanocortin-1 receptor. One reports activity surviving the loss of that receptor in a live animal, and one describes the tripeptide as the active core of the parent. No source cited here resolves them, and this page does not choose between them.

Corneal Wound Closure in Rabbits

Rabbit corneal epithelium was removed by mechanical abrasion in both eyes and drops were given four times daily for four days.^[5] The remaining epithelial defect was significantly smaller with the tripeptide than with vehicle at each time point.^[5] By sixty hours, eight of eight corneas given the tripeptide were completely re-epithelialised and none of the placebo corneas were.^[5] Giving a nitric oxide synthase inhibitor first blocked the effect.^[5] Cell viability in cultured rabbit corneal epithelial cells rose at 1 and 10 micromolar.^[5]

The authors state that the tripeptide may facilitate corneal healing through a mechanism that may involve nitric oxide.^[5]They add that it is not known whether this depends on a repairing activity shared by the whole alpha-MSH molecule.^[5]Both statements are hedges in the source and are carried here as hedges.^[5]

Effects on Microbes

A 2000 study tested alpha-MSH and its C-terminal tripeptide against the bacterium Staphylococcus aureus and the yeast Candida albicans.^[6] Both peptides significantly inhibited Staphylococcus aureus colony formation and reversed the enhancing effect of urokinase on it.^[6] Effects occurred across a broad range of concentrations including the picomolar range, and small concentrations reduced viability and germ tube formation in the yeast.^[6] Killing of both organisms by human neutrophils was not reduced by the peptides and was enhanced.^[6]

State of the Evidence

Roughly 140 records are indexed for this tripeptide, and this page leans on six of them. The intestinal work is the strongest part of the record. Two independent groups published in 2008 using different mouse models, and both reported benefit.^[2]Everything cited here is cell culture or animal work.

No human study of this tripeptide was found. A PubMed search filtered to clinical trials returns no record of it, so there is no dose, no safety profile and no efficacy figure in people to report.

The receptor question is unsettled in the published record. Nothing here is extrapolated from the parent. Alpha-MSH is a thirteen-residue peptide with its own literature and its own products on this site, and only results with the tripeptide itself appear above. Where a study tested both, the sentence names which molecule the result belongs to.